Melanie A. Kleinschek

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 11,878,977
- Issue date Jan 23, 2024
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treatment using a JAK inhibitor compound
- Patent number 11,786,517
- Issue date Oct 17, 2023
- Theravance Biopharma R&D IP, LLC
- Melanie A. Kleinschek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 11,667,637
- Issue date Jun 6, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treatment using a JAK inhibitor compound
- Patent number 10,548,886
- Issue date Feb 4, 2020
- Theravance Biopharma R&D IP, LLC
- Melanie A. Kleinschek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,550,118
- Issue date Feb 4, 2020
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 10,519,153
- Issue date Dec 31, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatment using a JAK inhibitor compound
- Patent number 10,406,148
- Issue date Sep 10, 2019
- Theravance Biopharma R&D IP, LLC
- Melanie A. Kleinschek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,392,386
- Issue date Aug 27, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of a JAK inhibitor compound
- Patent number 10,251,874
- Issue date Apr 9, 2019
- Theravance Biopharma R&D IP, LLC
- Marta Dabros
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 10,208,040
- Issue date Feb 19, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20230063643
- Publication date Mar 2, 2023
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20220289737
- Publication date Sep 15, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND
- Publication number 20220008403
- Publication date Jan 13, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- MELANIE A. KLEINSCHEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND
- Publication number 20190350916
- Publication date Nov 21, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- MELANIE A. KLEINSCHEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20190337945
- Publication date Nov 7, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20190127371
- Publication date May 2, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20190119275
- Publication date Apr 25, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND
- Publication number 20180311226
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Venkat R. THALLADI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND
- Publication number 20180311223
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- MARTA DABROS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
- Publication number 20180311255
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20180258088
- Publication date Sep 13, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20180258087
- Publication date Sep 13, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS
- Publication number 20130287775
- Publication date Oct 31, 2013
- Edward P. Bowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pathogenic TH17 Cells; related reagents and methods
- Publication number 20120156699
- Publication date Jun 21, 2012
- Schering Corporation
- Edward P. Bowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS
- Publication number 20100135998
- Publication date Jun 3, 2010
- Schering Corporation
- Edward Paul Bowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Melanie A. Kleinschek

Person

Patents Grantslast 30 patents

JAK inhibitors containing a 4-membered heterocyclic amide

Methods of treatment using a JAK inhibitor compound

Fused imidazo-piperidine JAK inhibitors

Methods of treatment using a JAK inhibitor compound

JAK inhibitors containing a 4-membered heterocyclic amide

Fused imidazo-piperidine JAK inhibitors

Methods of treatment using a JAK inhibitor compound

JAK inhibitors containing a 4-membered heterocyclic amide

Crystalline forms of a JAK inhibitor compound

Fused imidazo-piperidine JAK inhibitors

Patents Applicationslast 30 patents

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND

METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND

CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND

FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS

Pathogenic TH17 Cells; related reagents and methods

COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS